Beck J, et al. Profile of the circulating DNA in apparently healthy individuals. Clin Chem. 2009 Apr;55(4):730-8

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Beck J et al. Genome aberrations in canine mammary carcinomas and their detection in cell-free plasma DNA. PLoS One. 2013 Sep 30;8(9):e75485

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Oellerich M et al. Using Circulating Cell-free DNA to Monitor Personalized Cancer Therapy. Crit. Rev. Clin. Lab. Sci 2017; 54:205-218

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Beck J et al. Next generation sequencing of serum circulating nucleic acids from patients with invasive ductal breast cancer reveals differences to healthy and nonmalignant controls. Mol Cancer Res. 2010 Mar;8(3):335-42.

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Schütz E et al. Chromosomal instability in cell-free DNA is a serum biomarker for prostate cancer. Clin Chem. 2015 Jan;61(1):239-48

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Weiss GJ et al. Phase Ib/II study of gemcitabine, nab-paclitaxel, and pembrolizumab in metastatic pancreatic adenocarcinoma. Invest New Drugs (2017) Nov 8

By | September 27th, 2018|Cancer, Medical publications|0 Comments

Kundranda, MN et al. Tumor cell-free DNA copy number instability compared to CA19-9 as an early predictor of response to systemic therapy in pancreatic ductal adenocarcinoma (PDAC). J Clin Oncol (2017): suppl; e14524

Download PDF. copy

By | August 28th, 2018|Cancer, Medical publications|0 Comments

Schütz E et al. Combining Genome Change Index (GCI) and liquid biopsy to predict and monitor therapeutic responses. J Clin Oncol (2015): e22020

Download PDF

By | August 28th, 2018|Cancer, Medical publications|0 Comments

Beck J et al. Prognostic value of cell-free DNA in patients with oropharyngeal cancers. J Clin Oncol (2016): e17511

Download PDF

By | August 28th, 2018|Cancer, Medical publications|0 Comments

Weiss GJ et al. Changes in tumor cell-free DNA copy number instability (CNI) predict therapeutic response in metastatic cancers. Cancer Research (2016): suppl; a3138

Download PDF

By | August 28th, 2018|Cancer, Medical publications|0 Comments